Organization
LimmaTech Biologics
3 clinical trials
Clinical trial
Safety and Immunogenicity of a Shigella-Tetravalent Bioconjugate Vaccine: A Phase 1/2 Randomized Controlled and Age Descending Study Including Dose Finding in 9 Month Old InfantsStatus: Completed, Estimated PCD: 2022-09-01
Clinical trial
Candi5V01 A FTIH Phase I/II Randomized and Controlled Study to Test Safety, Immunogenicity and Preliminary Efficacy of a Pentavalent Bioconjugate Vaccine (Candi5V) Against Candida in Women With Recurrent Vulvovaginal Candidiasis.Status: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Administered to Healthy Adults: A FTIH Phase I/II Randomized and Controlled StudyStatus: Completed, Estimated PCD: 2022-09-26